AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SAB Biotherapeutics, Inc. Director's Dealing 2021

Oct 23, 2021

34961_dirs_2021-10-22_ece318e1-20d1-4ae5-9784-f4a675b82597.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Big Cypress Acquisition Corp. (SABS)
CIK: 0001833214
Period of Report: 2021-10-22

Reporting Person: Beyer Russell P (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2475	Direct